title: [Comparison of dosimetric properties of 15-MV-photons and 14-MeV-neutrons in external stereotaxic convergence therapy].
abstract: Dosimetric properties for stereotaxic convergent beam therapy techniques with small field sizes have been investigated as well as for the linear accelerator Mevatron 77 as for the neutron generator KARIN. Additionally we also measured the dose distribution of single plane rotational therapy. As an indication of quality we calculated the V50 ratio as V50 = (F50-F90)/F90 and the corresponding V20 values. For the single plane irradiation there is a considerable difference in dose distribution in favour of photons. V50 (axial) amounts to 1.77 for photons and to 2.7 for neutrons. For the convergential non coplaner arc-therapy using nine plans there is nearly no difference in the high dose region including the 50%-isodose. V50 (axial): 1.16 and 1.6 respectively; (frontal) 1.36 and 1.35 respectively. Regarding to physical dose distributions our results indicate, that 14-MeV neutrons are suitable for high dosed stereotactic single irradiations.
authors.affiliation: Institut für Radiologie und Pathophysiologie Deutsches Krebsforschungszentrum, Heidelberg.
authors.forename: K H
authors.initials: KH
authors.lastname: Höver
authors.forename: B M
authors.initials: BM
authors.lastname: Hesse
authors.forename: D
authors.initials: D
authors.lastname: Oetzel
authors.forename: B
authors.initials: B
authors.lastname: Rhein
authors.forename: W J
authors.initials: WJ
authors.lastname: Lorenz
authors.forename: R
authors.initials: R
authors.lastname: Engelhart
authors.forename: B
authors.initials: B
authors.lastname: Kimmig
authors.forename: M
authors.initials: M
authors.lastname: Wannenmacher
mesh_terms: D001932:Brain Neoplasms / Q000532:radiotherapy; D006801:Humans; D009502:Neutrons; D010315:Particle Accelerators; D011879:Radiotherapy Dosage; D013238:Stereotaxic Techniques
vernacular_title: Vergleich der dosimetrischen Eigenschaften von 15-MV-Photonen und 14-MeV-Neutronen bei der externen stereotaktischen Konvergenztherapie.